Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Physician Participants
1. At least 60% of time spent in direct participant care.
2. Board-certified or eligible with a Specialty in Ophthalmology, such as Retinal Specialist, IRD Specialist, Retinal Surgeon.
Patient Participants
1. CHM diagnosis confirmed via genetic testing.
2. Include any minimal disease severity requirement.
3. Participant has at least one record of visual acuity measurement in the past 24 months, OR has be assigned by the treating clinician as having severe VA impairment of blind/legally blind by using one of the following methods: finger counting, hand movement, light perception / no light perception.
You may not be if
Physician Participants
a. Participating physicians must not be affiliated with an approved management organization.
Patient Participants
a. Participants who received gene therapy or any other investigational treatment and participants who do not agree to informed consent.
Clareo Health | A Study to Assess Choroideremia (CHM) Health Outcomes
